Butyrate in energy metabolism: there is still more to learn

L Zhang, C Liu, Q Jiang, Y Yin - Trends in Endocrinology & Metabolism, 2021 - cell.com
Butyrate, a main product of gut microbial fermentation, has been recognized as an important
mediator of gut microbiota regulation in whole body energy homeostasis. However, the …

Targeting innate immune mediators in type 1 and type 2 diabetes

MY Donath, CA Dinarello… - Nature Reviews …, 2019 - nature.com
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …

Targeting the pancreatic β-cell to treat diabetes

A Vetere, A Choudhary, SM Burns… - Nature reviews Drug …, 2014 - nature.com
Diabetes is a leading cause of morbidity and mortality worldwide, and predicted to affect
over 500 million people by 2030. However, this growing burden of disease has not been met …

The human islet: mini-organ with mega-impact

JT Walker, DC Saunders, M Brissova… - Endocrine …, 2021 - academic.oup.com
This review focuses on the human pancreatic islet—including its structure, cell composition,
development, function, and dysfunction. After providing a historical timeline of key …

Integrative regulation of physiology by histone deacetylase 3

MJ Emmett, MA Lazar - Nature reviews Molecular cell biology, 2019 - nature.com
Cell-type-specific gene expression is physiologically modulated by the binding of
transcription factors to genomic enhancer sequences, to which chromatin modifiers such as …

Histone deacetylases as targets for treatment of multiple diseases

J Tang, H Yan, S Zhuang - Clinical science, 2013 - portlandpress.com
HDACs (histone deacetylases) are a group of enzymes that deacetylate histones as well as
non-histone proteins. They are known as modulators of gene transcription and are …

Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review

R Sarkar, S Banerjee, SA Amin, N Adhikari… - European journal of …, 2020 - Elsevier
Abstract Among different Histone deacetylases (HDACs), histone deacetylase 3 (HDAC3) is
an epigenetic drug target which is currently marked as a potential therapeutic strategy to …

Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic …

S Khan, GB Jena - Chemico-biological interactions, 2014 - Elsevier
Abstract Type 1 diabetes (T1D) also known as juvenile diabetes is a chronic autoimmune
disorder that precipitates in genetically susceptible individuals by environmental factors …

Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy

N Adhikari, T Jha, B Ghosh - Journal of Medicinal Chemistry, 2021 - ACS Publications
The acetylation of histone and non-histone proteins has been implicated in several disease
states. Modulation of such epigenetic modifications has therefore made histone …

Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif

FF Wagner, DE Olson, JP Gale, T Kaya… - Journal of medicinal …, 2013 - ACS Publications
Hydroxamic acids were designed, synthesized, and evaluated for their ability to selectively
inhibit human histone deacetylase 6 (HDAC6). Several inhibitors, including compound 14 …